Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 8;12(1):74.
doi: 10.3390/jpm12010074.

Targeted Therapy in Leukaemia, Lymphoma and Myeloma

Stephen Samuel Opat  1
Affiliations
Editorial

Targeted Therapy in Leukaemia, Lymphoma and Myeloma

Stephen Samuel Opat. J Pers Med. .

Abstract

Historically, most advances in cancer therapy have been pioneered by clinicians managing the blood diseases [...].

PubMed Disclaimer

Conflict of interest statement

The author has received honoraria from AbbVie, Roche, AstraZeneca, Merck, Gilead, Janssen, and Novartis; has a consulting or advisory role for AbbVie, Roche, AstraZeneca and Merck; received research funding from BeiGene, Roche, AstraZeneca, Janssen, Merck, Amgen and Epizyme.

References

    1. Pusey W.A. Cases of sarcoma and of Hodgkin’s disease treated by exposure to x-rays: A preliminary report. JAMA. 1902;38:166–169. doi: 10.1001/jama.1902.62480030024001h. - DOI
    1. Farber S.N., Diamond L.K., Mercer R.D., Sylvester R.F., Wolff J.A. Temporary remissions in acute leukaemia in children produced by folic acide antagonist, 4-aminopteroyl-glutamic acid (aminopterin) N. Engl. J. Med. 1948;238:787–793. doi: 10.1056/NEJM194806032382301. - DOI - PubMed
    1. Nowell P., Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497. - PubMed
    1. Rowley J. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining. Nature. 1973;243:290–293. doi: 10.1038/243290a0. - DOI - PubMed
    1. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., et al. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia. N. Engl. J. Med. 2001;344:1031–1037. - PubMed

Publication types

LinkOut - more resources